Yarlagadda S Babu Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Yarlagadda S Babu.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yarlagadda S Babu. Yarlagadda S Babu is Senior VP - Drug Discovery in BIOCRYST PHARMACEUTICALS INC ($BCRX) and VP Drug Discovery in BIOCRYST PHARMACEUTICALS INC ($BCRX).
Latest Insider Trading Transactions of Yarlagadda S Babu
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 11.17 | 4,362 | 48,724 | 210,331 | 214.7 K to 210.3 K (-2.03 %) |
| Jan 05 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 12.16 | 42,400 | 515,584 | 42,400 | |
| Jan 05 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 12.16 | 2,402 | 29,208 | 214,693 | 217.1 K to 214.7 K (-1.11 %) |
| Jan 05 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Grant | A | 0.00 | 8,900 | 0 | 217,095 | 208.2 K to 217.1 K (+4.27 %) |
| Dec 23 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
| May 28 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 8.83 | 23,679 | 209,086 | 0 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 4.30 | 2,929 | 12,595 | 0 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 8.83 | 2,208 | 19,497 | 0 | |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Sell | S | 12.57 | 40,642 | 510,870 | 208,195 | 248.8 K to 208.2 K (-16.33 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 8.83 | 23,679 | 209,086 | 248,837 | 225.2 K to 248.8 K (+10.52 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 4.30 | 2,929 | 12,595 | 225,158 | 222.2 K to 225.2 K (+1.32 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 8.83 | 2,208 | 19,497 | 222,229 | 220 K to 222.2 K (+1.00 %) |
| Mar 07 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 11.69 | 1,618 | 18,914 | 220,021 | 221.6 K to 220 K (-0.73 %) |
| Feb 25 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 4.30 | 23,179 | 99,670 | 0 | |
| Feb 25 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 12.20 | 8,170 | 99,674 | 221,639 | 229.8 K to 221.6 K (-3.56 %) |
| Feb 25 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 4.30 | 23,179 | 99,670 | 229,809 | 206.6 K to 229.8 K (+11.22 %) |
| Feb 04 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 10.80 | 35,000 | 378,000 | 35,000 | |
| Feb 04 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Grant | A | 0.00 | 54,000 | 0 | 206,630 | 152.6 K to 206.6 K (+35.38 %) |
| Jan 03 2014 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Payment of Exercise | F | 7.60 | 2,402 | 18,255 | 152,630 | 155 K to 152.6 K (-1.55 %) |
| Mar 06 2013 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Payment of Exercise | F | 1.19 | 1,903 | 2,265 | 155,032 | 156.9 K to 155 K (-1.21 %) |
| Jan 07 2013 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | A | 1.42 | 50,000 | 71,000 | 50,000 | |
| Jan 07 2013 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | A | 1.42 | 50,000 | 71,000 | 50,000 | |
| Jan 07 2013 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Grant | A | 0.00 | 8,500 | 0 | 156,935 | 148.4 K to 156.9 K (+5.73 %) |
| Jan 07 2013 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Grant | A | 0.00 | 8,500 | 0 | 148,435 | 139.9 K to 148.4 K (+6.07 %) |
| Mar 19 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Payment of Exercise | F | 5.23 | 6,872 | 35,941 | 139,935 | 146.8 K to 139.9 K (-4.68 %) |
| Mar 19 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Grant | A | 0.00 | 21,038 | 0 | 146,807 | 125.8 K to 146.8 K (+16.73 %) |
| Feb 23 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | M | 1.20 | 23,821 | 28,585 | 76,179 | |
| Feb 23 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | M | 1.04 | 1,226 | 1,275 | 0 | |
| Feb 23 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | M | 1.18 | 5,865 | 6,921 | 0 | |
| Feb 23 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 4.22 | 30,912 | 130,449 | 52,738 | 83.7 K to 52.7 K (-36.95 %) |
| Feb 23 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Buy | M | 1.20 | 23,821 | 28,585 | 83,650 | 59.8 K to 83.7 K (+39.82 %) |
| Feb 23 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Buy | M | 1.04 | 1,226 | 1,275 | 59,829 | 58.6 K to 59.8 K (+2.09 %) |
| Feb 23 2012 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Buy | M | 1.18 | 5,865 | 6,921 | 58,603 | 52.7 K to 58.6 K (+11.12 %) |
Page: 1